TORONTO, Jan. 25, 2021 /PRNewswire-PRWeb/ -- There is a need for creating more equitable clinical trials, but how do we go about planning them? To succeed at this goal, we must ask ourselves, how do we go about overcoming the myth that inclusive/diverse trials can only be achieved through a quota system – and that the pursuit of more equitable trials subverts timelines? In the second session of this four-part series, this active panel discussion – including clinical operations leaders representing perspectives across biopharma – will discuss how to achieve "a new normal," with practical day-to-day solutions designed to drive adoption of patient diversity in clinical trials.
Join Moderator Nicholas Kenny, Chief Scientific Officer, Syneos Health; Julian Jenkins, PhD, Group Vice President and Head of Development Operations and Project Management, Incyte Corporation; Jim Kremidas, Executive Director, Association for Clinical Research Professionals (ACRP); Worta McCaskill-Stevens, MD, MS, Chief, Community Oncology and Prevention Trials Research Group, NCI Community Oncology Research Program; and Cathy Trzaskawka ("Traz"), Executive Director and Head, Global Advocacy, Bristol-Myers Squibb in a live webinar on Wednesday, February 3, 2021 at 12pm EST.
For more information, or to register for this event, visit Overcoming Operational Challenges: How Intentional Planning Leads to Patient Diversity in Clinical Trials.
Blazing a Trail to Clinical Trial Diversity Webinar Series
This four-part webinar series will identify obstacles that have to-date, and continue to, stifle appropriate patient diversity in clinical trials; unpacking the organizational overhaul needed to effect change; sharing case studies where sponsors, patients and investigators have come together to overcome hurdles; and exploring how policy innovations that might include government-led mandates and incentives can move the industry forward together. Speakers include experts from the Association for Clinical Research Professionals (ACRP), Bristol Myers Squibb, Emory-Winship Cancer Center, Incyte Corporation, NCI Community Oncology Research Program (NCORP) and the Society for Clinical Research Sites (SCRS).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
About Syneos Health
Syneos Health® is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers' delivery of important therapies to patients. To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.
Sydney Perelmutter, Xtalks, +1 (416) 977-6555 x 352, [email protected]